May 6, 2024, 5:29 p.m. | Dr. Tony Hoang

The Artificial Intelligence Podcast linktr.ee

Scientists at UC San Diego have developed a new AI platform called POLYGON that has the potential to revolutionize drug discovery. Unlike existing protocols, POLYGON can identify molecules with multiple targets, which is significant as multi-target drugs have the potential to deliver the same benefits as combination therapy, but with fewer side effects. To train POLYGON, researchers used a database of over a million known bioactive molecules, allowing it to generate new candidate drugs with specific properties. They synthesized 32 …

ai platform benefits combination discovery drug discovery drugs effects game identify molecules multiple platform polygon scientists targets therapy uc san diego

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US